Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
News Release Digital Asset Direct

Nansen Collaborates with TRON DAO to Empower Developers and Users with Advanced Blockchain Insights

Nansen

Singapore, November 19, 2024 — Leading blockchain data provider Nansen announced its collaboration with TRON DAO, a community-governed DAO dedicated to accelerating the decentralization of the internet via blockchain technology and dApps. TRON, the trusted network for developers, institutions, and individuals worldwide, will be fully integrated on Nansen 2. This collaboration aims to supercharge the TRON ecosystem by providing users and developers with unparalleled insights into on-chain data. TRON is a decentralized blockchain network that enables developers to build and deploy decentralized applications (dApps). Powered by smart contracts and a delegated proof-of-stake (DPoS) consensus mechanism, TRON offers high speed, scalability, and low fees. The TRON Virtual Machine (TVM) provides a robust environment for efficient smart contract execution and migration from Ethereum with a resource model allowing users to reduce on-chain gas fees to $0 or near $0. With its versatile capabilities, TRON has become a leading blockchain, supporting a wide range of use cases including payments, gaming, multimedia, art, and DeFi. "Nansen is thrilled to collaborate with TRON DAO. TRON's unique architecture combines high speed, scalability, and low fees with a user-friendly interface, making it a powerhouse in the blockchain space. By bringing Nansen's cutting-edge, real-time analytics to this rapidly growing ecosystem, we're empowering users to unlock the platform’s full potential. This collaboration is a testament to our shared commitment to driving growth and adoption in the blockchain space." - Alex Svanevik, CEO of Nansen. "The TRON network is a leader in blockchain innovation, and the integration with Nansen will improve how developers and the community interact with the ecosystem. With advanced analytics and on-chain data insights, developers will have access to more tools and resources to build and optimize their DApps, while enabling greater transparency within the community." —Justin Sun, Founder of TRON. TRON has emerged as a dominant force for Tether (USDT) adoption, with 22.7 million holders on TRON compared to 4.2 million holders on Ethereum. This data underscores TRON's low-fee, scalable infrastructure, which has made it a preferred network for stablecoin usage. In just the last 24 hours, TRON’s daily transactions peaked at 6.94 million, further highlighting the platform’s scalability and its massive user activity. Along with this announcement, Nansen is launching the TRON Macro Dashboard, providing investors and developers with an unprecedented view of the TRON ecosystem. This powerful tool will offer real-time, actionable insights that cut through the noise, helping users pinpoint high-value opportunities faster than ever before. This dashboard will offer key insights into the ecosystem's activity and performance, including features like Token God Mode (TGM), Wallet Profiler, Hot Contracts, Wallet Profiler for Tokens (WP4T), Wallet Pair Profiler, Token Overlap, Token Screener and Smart Alerts. About Nansen Nansen is a blockchain analytics platform that enriches on-chain data with millions of wallet labels. Crypto investors use Nansen to discover opportunities, perform due diligence, and defend their portfolios with our real-time dashboards and alerts. Visit https://nansen.ai to find out more. Media Contact Shennon nansen@hokkupr.com About TRON TRON DAO is a community-governed DAO dedicated to accelerating the decentralization of the internet via blockchain technology and dApps. Founded in September 2017 by H.E. Justin Sun, the TRON network has continued to deliver impressive achievements since MainNet launch in May 2018. July 2018 also marked the integration of BitTorrent, a pioneer in decentralized Web3 services boasting over 100 million monthly active users. The TRON network has gained incredible traction in recent years. As of November 2024, it has over 270 million total user accounts on the blockchain, more than 8 billion total transactions, and over $16 billion in total value locked (TVL), as reported on TRONSCAN. In addition, TRON hosts the largest circulating supply of USD Tether (USDT) stablecoin across the globe, overtaking USDT on Ethereum since April 2021. The TRON network completed full decentralization in December 2021 and is now a community-governed DAO. Most recently in October 2022, TRON was designated as the national blockchain for the Commonwealth of Dominica, which marks the first time a major public blockchain partnered with a sovereign nation to develop its national blockchain infrastructure. On top of the government’s endorsement to issue Dominica Coin (“DMC”), a blockchain-based fan token to help promote Dominica’s global fanfare, seven existing TRON-based tokens - TRX, BTT, NFT, JST, USDD, USDT, TUSD, have been granted statutory status as authorized digital currency and medium of exchange in the country. TRONNetwork | TRONDAO | Twitter | YouTube | Telegram | Discord | Reddit | GitHub | Medium | Forum Media Contact Yeweon Park press@tron.network Contact Details Shennon nansen@hokkupr.com

November 19, 2024 12:55 PM Eastern Standard Time

Image

PathAI Announces Integrations with Leading AI-pathology Companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System

PathAI

PathAI, a global leader in AI-powered digital pathology solutions and the developer of the market-leading AISight 1 Image Management System (IMS), today announced the integration of several AI products from market leading digital pathology companies, including Deep Bio, DoMore Diagnostics, Paige, and Visiopharm. Through these collaborations, PathAI will provide algorithms from these developers directly within its AISight IMS, reinforcing its commitment to offering the most versatile, reliable, and interoperable IMS on the market. Deep Bio "Integrating Deep Bio's DeepDx Prostate with PathAI's AISight platform marks an important step forward in prostate cancer diagnostics, combining AI-driven pathology insights with robust image management capabilities to support streamlined workflows," said Sun Woo Kim, CEO of Deep Bio. "This collaboration brings advanced data-driven tools to the hands of pathologists globally, enabling more efficient pathology processes and reinforcing our commitment to innovation in cancer diagnostics." — DoMore Diagnostics “DoMore Diagnostics and PathAI have a shared vision to realize the promise of digital pathology and outcome prediction to improve the lives of patients worldwide,” said Torbjørn Furuseth, Co-Founder and CEO of DoMore Diagnostics. “The AISight platform is set to spearhead innovations in the field going forward and will be a key partner as we continue our mission to personalize cancer treatment for patients worldwide with our Histotype Px digital biomarker.” — Paige "We see the partnership with PathAI as an important step forward for digital pathology; as the two leaders in this space, by offering our solutions together, pathologists can benefit from all the best things the industry can offer," said Peter Hamilton, GM of Diagnostics. — Visiopharm “We are delighted to collaborate with PathAI to bring our portfolio of fully automated, zero-click AI-driven diagnostic and translational solutions for breast and lung cancer to a broader audience. Our commitment is to expand access to precision pathology on leading platforms. Becoming a preferred partner for PathAI's AISight Image Management System is an important step towards this goal. With our platform-agnostic technology designed for seamless integration, we look forward to working closely with the PathAI team to accelerate the adoption of digital pathology worldwide, ultimately enhancing lab efficiency and improving the quality of patient care,” said Michael Grunkin, CEO Visiopharm — Utilizing the AISight IMS, partner laboratories will be able to seamlessly access a diverse portfolio of digital pathology algorithms from leading global AI companies. Through these deep integrations pathologists will benefit from rich visual support, including AI-generated overlays, and embedded quantitative results driving differentiated workflows. This integrated user experience will allow labs to realize the most value from algorithm product usage in their routine lab workflows. AISight’s growing portfolio of algorithms supports various needs, including workflow optimization, biomarker quantification, risk stratification, slide quality control, and tumor sufficiency. These integrations are powered by AISight Link, an open API that allows algorithm developers to leverage the platform’s advanced features, including AI Impressions, Fields of Interest, and comprehensive reporting tools. “These partnerships are a testament to our commitment to building a robust ecosystem of AI and digital pathology innovators,” said Andy Beck, MD, PhD, co-founder and CEO of PathAI. “Through AISight Link, we ensure seamless interoperability between AISight and third-party AI algorithms, as well as integration with Laboratory Information Systems (LIS) and other essential IT infrastructure in modern pathology labs. We are excited to collaborate with labs and AI developers to collectively drive improvements in patient outcomes.” For more information about PathAI, AISight, or the expanding algorithm catalog, please contact digital.dx@pathai.com or visit pathai.com. 1 AISight is for Research Use Only in the US; AISight Dx is CE-IVDR in Europe and UKCA in UK About PathAI PathAI is a global leader in AI-powered digital pathology solutions, dedicated to improving operational efficiency in pathology labs worldwide. Through its innovative technology and strategic partnerships, PathAI is shaping the future of medical diagnostics and advancing patient care across the globe. About Deep Bio Deep Bio is a pioneer in AI-powered pathology, transforming cancer diagnostics with innovative solutions that support pathologists in delivering precise and efficient care. Its flagship product, DeepDx Prostate, is a CE-IVD-marked diagnostic aid extensively vetted through studies of over 700,000 U.S. biopsy specimens. Offering tools for cancer detection, Gleason scoring, and gland-level tumor analysis, DeepDx Prostate enhances diagnostic accuracy while streamlining pathology workflows. Deep Bio's commitment to advancing digital pathology is driven by collaboration and a dedication to improving patient outcomes. About DoMore Diagnostics DoMore Diagnostics uses artificial intelligence to make personalized treatment decisions simple and accessible for all cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists' existing workflow. The lead product Histotype Px ® Colorectal is a CE-IVDD marked outcome prediction marker for stage II and III colorectal adenocarcinoma that informs the decision of whether to provide adjuvant chemotherapy following surgical resection of the tumor. About Paige Paige's AI applications are developed using extensive and diverse datasets and leverage advanced AI technologies. Thoughtfully designed, rigorously tested, and trusted by pathologists worldwide for their performance. By automating traditionally burdensome and tedious manual tasks, Paige's AI applications alleviate time and resource pressures for pathologists. All of Paige's AI suites including Prostate, Breast, Colon, Pan-Cancer, and the new biomarker screening application, OmniScreen™ will be made available within PathAI's digital pathology solution, AISight. About Visiopharm Visiopharm is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader within clinical applications, with no fewer than nine diagnostic algorithms cleared under IVDR for EU and UK customers. These applications provide diagnostic decision support and can be easily activated and integrated into existing lab workflows. Founded in 2002, Visiopharm is privately owned and operates internationally with over 750 customer accounts in more than 40 countries. The company's headquarters are located in Denmark's Medicon Valley, with legal entities in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

November 19, 2024 09:19 AM Eastern Standard Time

F1rst Motors Launches a Car Selling Platform on Their Official Website

Rev Up Marketers

Founded in 2021 as part of the esteemed Alpago Group, F1rst Motors—a leading luxury and hypercar dealership—is pleased to announce the launch of a new online platform for individuals interested in selling their vehicles in Dubai. This innovative platform offers an efficient, user-friendly solution for car owners, allowing them to list their luxury vehicles directly on F1rst Motors’ website. Users can upload vehicle details with just a few clicks, streamlining the process. Once listed, the F1rst Motors sales team actively works to connect sellers with potential buyers. If a suitable buyer is found, F1rst Motors manages all post-sale procedures, ensuring a seamless and secure transaction for both sellers and buyers. This initiative underscores F1rst Motors' commitment to enhancing its presence in Dubai’s dynamic automotive market, showcasing both its success and the continued support from its parent organization. As part of its expansion, F1rst Motors has also introduced additional services, including a platform for buying and selling exclusive number plates —highly prized assets within Dubai’s social landscape. With the region’s record-breaking license plate auctions, this new offering allows F1rst Motors to connect with a unique and valuable market. F1rst Motors has cultivated a strong following among local and international luxury car enthusiasts, reinforcing its reputation as a premier destination for collectors. The company's commitment to providing an unparalleled experience for its clients has cemented its position as a leader in the luxury automotive sector. Beyond its recent platform launches, F1rst Motors has made headlines with the sale of exclusive vehicles, including a 2014 Lamborghini Veneno Roadster —an ultra-rare model and the only one of its kind with a full carbon fiber body. Launched in 2013, the Veneno's unique, futuristic design has earned it the nickname “Batmobile” for its aggressive, powerful lines. With a 6.5L V-12 naturally aspirated engine, a top speed of 355 km/h, and 750 horsepower delivered through a 7-speed ISR transmission, the Veneno embodies the high-performance standards upheld by F1rst Motors. About F1rst Motors recently had the honor of hosting a two-time Formula 1 World Champion, further solidifying its reputation among elite clientele. Under the leadership of CEO Ali Pacino, F1rst Motors continues to set the standard in Dubai’s luxury car sector, offering exclusive vehicles and tailored services for discerning collectors and enthusiasts. With the strategic guidance of the Alpago Group, F1rst Motors is poised to expand its influence and redefine the luxury automotive experience in Dubai. Contact Details F1rst Motors Hamed Karimi marketing@f1rstmotors.com Company Website https://f1rstmotors.com/

November 19, 2024 09:07 AM Eastern Standard Time

Image

NAVEX Empowers Small and Medium-Sized Businesses to Create a Culture of Compliance

NAVEX Global

NAVEX, the global leader in integrated risk and compliance management software, now makes it even easier for small and medium-sized businesses (SMBs) to start and scale their governance, risk, and compliance (GRC) programs. With a long history of serving over 6,000 SMBs worldwide, the company understands the unique challenges these businesses face. As regulatory scrutiny intensifies and partnerships with larger enterprises expand, SMBs must adhere to complex compliance standards while positioning themselves for future growth, such as mergers and acquisitions. “Global regulations, like the EU Whistleblower Protection Directive, can be daunting for smaller businesses,” explains NAVEX Chief Product Officer, A.G. Lambert. “NAVEX solutions such as WhistleB offer essentials like report intake, streamlined reporting, and case resolution while giving SMBs easy to use, effective, and fully compliant options.” They often take a reactive approach to risk and compliance topics due to their perceived complexity and lack of full-time ownership. Indeed, according to NAVEX research, 42% of risk and compliance professionals at small and medium-sized businesses have other non-compliance responsibilities. Yet, overlooking compliance can carry a heavy cost, from fines and reputational damage to lost business and revenue. Driving speak up compliance with NAVEX To comply with EU whistleblowing regulations, all EU businesses with 50 employees or more must provide a confidential speak-up channel. Businesses can stay compliant with these policies using NAVEX WhistleB, a smart and simple solution that ensures all whistleblower reports are managed in sync with legal obligations. It provides peace of mind and focuses on EU regulatory compliance, SOC 2 Type II (all data processed by NAVEX WhistleB is stored in the EU), and efficient case management. Key features of NAVEX WhistleB include: Fast, secure report intake on incidents, compliance issues or potential risks. Clear, compliant incident management processes designed for speed and simplicity. Assured confidentiality and security to build trust in the speak-up program. Building a risk aware culture NAVEX provides SMBs with solutions that grow with their business, helping them build future-ready, risk aware corporate cultures. From compliance training to policies and procedures, NAVEX empowers them to establish a GRC program that complies with regulations and strengthens employee participation. Intuitive design meets expert guidance with the NAVEX WhistleB whistleblowing system, which is now available to purchase online, please visit the website. For advice and tips on how to manage compliance for SMBs, read our helpful guides: Guide to SMB compliance Understanding evolving cybersecurity risks 2024 State of SMB compliance Ethics and compliance programs for SMBs NAVEX is trusted by thousands of customers worldwide to help them achieve the business outcomes that matter most. As the global leader in integrated risk and compliance management software and services, we deliver solutions through the NAVEX One platform, the industry’s most comprehensive governance, risk and compliance (GRC) information system. For more information, visit NAVEX.com and our blog. Follow us on Twitter and LinkedIn. Contact Details NAVEX +1 617-388-5773 anita.lo@navex.com Company Website https://navex.com

November 19, 2024 09:02 AM Eastern Standard Time

Power2Practice Unveils Strategic Partnership with Evexia Diagnostics to Revolutionize Lab Ordering and Patient Outcomes

Power2Practice

Power2Practice, the first specialized integrative and functional medicine EMR and practice management platform, is thrilled to announce a partnership with Evexia Diagnostics. This integration will enable healthcare providers to order and manage all labs seamlessly within a single, streamlined platform. Learn more about the Power2Practice and Evexia Diagnostics Partnership. Phil Hagerman, CEO, Power2Practice: “Integrating with Evexia Diagnostics is a game changer in lab order management, transforming the way our users streamline their workflows while elevating patient care and accessibility. This partnership reflects our dedication to optimizing the healthcare experience for providers and empowering patients with timely, accessible insights.” Marking a breakthrough in lab ordering efficiency, the collaboration is designed to simplify lab ordering for enhanced practice efficiency and improved patient outcomes while unlocking new revenue opportunities for practices. Dr. Kevin K. Bodling, President, Evexia Diagnostics: “This is a transformative step toward making lab services more accessible and affordable for providers and patients. By embedding our comprehensive lab solutions directly into Power2Practice, we’re equipping practitioners to deliver faster, more economical care. Together, we’re changing the landscape for integrative and functional medicine, enabling providers to leverage lab insights for optimal patient outcomes like never before." Discover the Key Benefits of the Power2Practice + Evexia Partnership: 1. Seamless Lab Ordering: Providers can easily order from their preferred labs directly within the Power2Practice EMR, resulting in a more efficient workflow that saves valuable time and reduces administrative burdens. 2. Cost Reduction: Evexia Diagnostics provides discounted cash pricing, allowing patients to save up to 90% on lab costs compared to traditional billing practices, facilitating easier access to necessary testing. 3. Boost Profitability: Leveraging competitive pricing and streamlined processes enhances practice profitability, allowing providers to offer valuable, affordable lab services to their patients. 4.Enhanced Patient Care: The cash-pay model empowers healthcare providers and patients to operate outside the limitations of insurance, enabling decisions that prioritize quality and affordability in care. Ryan L. Obermeier, Chief Commercial Officer, Evexia Diagnostics: "Our partnership with Power2Practice is a significant leap forward for integrative and functional medicine professionals. By integrating seamless access to over 10,000 tests from 40+ leading labs into P2P, clinicians gain faster, more precise lab results with expert interpretation. Our white-glove service ensures exceptional provider support, and our group purchasing power delivers cost savings. Together, we’re simplifying and elevating the care experience for both providers and their patients." Learn more about this partnership and experience the benefits firsthand! Visit Power2Practice at the upcoming A4M Tradeshow, booth #7072, or sign up for the P2P Evexia demo waitlist. About Evexia Diagnostics Evexia Diagnostics provides a comprehensive selection of cutting-edge clinical laboratory services at unbeatable prices. Streamline and simplify your practice, while expanding the options you’re able to offer your clients, at the very same time. Learn more. About Power2Practice Power2Practice is an innovative healthcare technology platform designed specifically for integrative and functional medicine practitioners. Offering a comprehensive suite of tools, Power2Practice streamlines practice management, enhances patient engagement, and simplifies lab integration to improve efficiency and care delivery. With features like telemedicine, automated patient communication, and customizable protocols, the platform empowers practitioners to deliver personalized, data-driven care. Power2Practice is committed to advancing the field of integrative medicine by providing the tools and support practitioners need to grow their practices and improve patient outcomes. Learn more. Contact Details Power2Practice Britt Wittelsberger +1 410-852-0738 marketing@power2practice.com Company Website https://power2practice.com/

November 19, 2024 08:50 AM Eastern Standard Time

Investment Firms AGP, Northland Initiate Coverage On Bitdeer (NASDAQ: BTDR) With Buy Ratings And Targets Close To 100% Higher – What's Driving The Hype?

Benzinga

By Gerelyn Terzo, Benzinga With the broader stock market flirting with record territory once again, the bulls seem to be in control for the moment. As of mid-October, the S&P 500 index has advanced 22.4%, fueled by technology stocks like Nvidia (Nasdaq: NVDA) that are leading the generative AI race. Furthermore, even the Dow Jones Industrial Average advanced on Thursday to its fourth record close in five sessions on Oct. 17. One stock that also seems to have received some attention due to the positive Wall Street sentiment is Bitdeer Technologies Group (NASDAQ: BTDR), which continues to capture analysts’ attention. After debuting on the stock market in 2023 through a business combination with Blue Safari Group, Bitdeer stock has traded in a range of $2.77-$14.77 over the past 52-week period as of Oct. 18. While technology leaders have been fueling the broader stock market rally in 2024, Bitdeer isn’t riding on any coattails. The company feels that there is a great deal for it to be excited about, not least of which is the deployment of half-a-dozen mining data centers across the U.S., Norway and Bhutan, plus additional capacity in the pipeline. This seems to have caused some Wall Street analysts to take notice. Most recently, two new equity research firms have initiated coverage on Bitdeer stock, proving they want to document the company’s growth story fueled by innovations like cutting-edge Bitcoin mining equipment, global data centers, AI, strategic partnerships and more. Investors who are interested in learning more about Bitdeer’s stock can do so here. Northland Capital Markets Expects Bitdeer Stock To Outperform Last month, Northland Capital Markets analyst Mike Grondahl initiated coverage on Bitdeer stock with an “outperform” rating. The analyst firm predicts the stock price will nearly double from its then price of $7.07 to $13 per share in the near term. As of Oct. 17, the price of the stock stood at close to $8. Northland’s Grondahl reports that he is encouraged by several tailwinds at Bitdeer’s back, including its early-mover positioning, which allows it to capitalize on ongoing trends in growing market segments in Bitcoin mining – including both hosted and self-mining capabilities – as well as high-performance computing (HPC) for AI and machine learning. Bitdeer reports that its strategically located data centers in Texas, Ohio, Norway and Bhutan – the latter two of which are new facilities – allow it to benefit from stable, inexpensive power that’s key for the efficiency of BTC mining and HPC operations. The analyst touted Bitdeer’s milestone of securing a lease agreement with the Monroe County Port Authority, adding up to 570 MW of power capacity to its Ohio facility and demonstrating favorable relationships within these communities. Additionally, Bitdeer also reports having a distinct advantage in the competitive landscape given its attractive and unique offerings, including its “BTC/ASIC mining chip and rig production operation” and its SEAL Bitcoin mining chip suite and SEALMINER A1 Bitcoin mining machine, which is on track for mass production in Q4 2024. While the company continues to advance its product pipeline, it’s not resting on its laurels and continues to innovate, with a robust pipeline of future upgrades, offerings and expansions to look forward to. On fundamentals, Northland’s analyst appears to be impressed with Bitdeer’s rising gross profit margins amid soaring revenue and the stock’s valuation, which he believes is not currently truly appreciating the company’s potential. The Northland analyst is also encouraged by Bitdeer’s expansion plans, as the company continues to grow its hashrate and contracted power capacity while also remaining positioned to capitalize on booming AI and HPC demand with no signs of relenting. Alliance Global Partners Advises Investors To Buy Bitdeer Stock Alliance Global Partners (AGP) Analyst Brian Kinstlinger also initiated coverage on Bitdeer stock in October with a “buy” rating. He has attached a $14 price target, similarly suggesting that the stock will likely almost double from the date the report was published. Among the highlights of his maiden report on BTDR stock, Kinstlinger emphasized Bitdeer’s self-mining hash rate, which could be set to nearly quadruple between Q3 2024 and year-end 2025. AGP focused strongly on Bitdeer’s growing fundamentals as well as its healthy and strong balance sheet as catalysts for the stock. The AGP analyst also took note of Bitdeer’s diversified business operations, which shield it from the inherent volatility in the Bitcoin price, allowing it to capture what he called “favorable economics for several years during bull cycles.” Meanwhile, Bitdeer’s ASIC miners are also on most stakeholders’ radars, given their ability to bolster the company’s hash rate and provide a competitive edge among Bitcoin miners. On the AI/HPC side, AGP’s Kinstlinger believes that Bitdeer has developed the right infrastructure to secure contracts with the potential to bolster the company’s revenue streams for multiple years to come. On that note, the analyst predicts revenue of $343 million and $446 million in 2024 and 2025, respectively, as well as EBITDA of $22 million and $66 million in those periods, before any of Bitdeer’s ASIC miner sales. AGP is encouraged by the $213 million cash on Bitdeer’s balance sheet, far surpassing its $38 million in debt. Bitdeer To Finish 2024 Strong? While there’s no crystal ball for the future direction of stock prices, Bitdeer certainly seems to be gaining attention on Wall Street. With growing revenues, EBITDA and profit margins, the company’s fundamentals are appealing to multiple analysts. Given its specialization in burgeoning areas of technology, including Bitcoin mining, artificial intelligence and high-performance computing, Bitdeer has an early-mover advantage compared to many of its competitors, which could give it staying power for the long haul. Investors can learn more about what to expect from Bitdeer here. Featured photo by TreptowerAlex on Pixabay. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 19, 2024 08:30 AM Eastern Standard Time

Image

Media and Democracy Project Urges FCC to Establish a 'Bright-Line Test' with Hearing on FOX Affiliate’s Broadcast License

Media and Democracy Project

Today, the Media and Democracy Project (MAD), joined by a bipartisan coalition of prominent former FCC officials, legal experts, and media advocates, filed further comments with the Federal Communications Commission (FCC) urging the agency to designate the WTXF-TV broadcast license application for a hearing. In its filing, the coalition asserts that this matter is not controversial nor political and that action by the Commission is a straightforward application of its statutory obligations. “Our petition is not about speech or political slant—it’s about the deliberate business decision by the Murdochs and Fox to lie to the American people about the 2020 election to protect the company’s profits,” said Brian Hansbury, Co-Founder of the Media and Democracy Project. “That decision cannot be squared with the character requirements of the Communications Act, and the FCC has the opportunity to prove that its public interest policy matters.” The filing argues that this case is “easily distinguishable from routine complaints by politicians about the political slant of a particular channel or classic journalistic prerogatives.” The group calls for the Commission to establish a “bright-line test to provide clear guidance on when a hearing is required.” The filing continues, “[p]roviding this guidance also would be a crowning addition to this Commission’s legacy.” “Commissioner Carr’s recent threat against the broadcast industry (an echo of Trump’s threat against ABC and CBS – against whom there has been no judicial finding) illustrates the importance of this commission adopting a more clear bright line test that invokes the character provision of the communications act only after there has been a judicial finding,” said former Murdoch lobbyist Preston Padden. “If the FCC fails to act, it risks setting a dangerous precedent that undermines its own authority and the public’s trust in broadcast media.” In urging Commission action, the group also called on the FCC to pay particular attention to three passages from earlier informal comments: In an earlier filing from Former FCC Chairman Alfred Sikes, the radio station owner recounted preparing his first application for a station license. It required him to commit to operate in the ‘public interest.’ He recalled wondering whether that language was “just some bureaucratic construct or a legally enforceable requirement.” Later, after serving as Chairman of the Commission, he notes that “the answer is still elusive.” In an informal objection, Former FCC Commissioner Ervin S. Duggan and former Editor of The Weekly Standard Bill Kristol, cited Judge Davis’s findings in US Dominion, Inc. v. Fox News Network, emphasizing that Fox’s behavior “is not consistent with the FCC’s character requirements for broadcast licensees who are supposed to operate their stations in the public interest first and foremost.” The pair continued, “given that the Murdoch/Fox lies contributed to the January 6 riot in the Capitol and duped millions of Americans into believing that the election was stolen, their actions shocked the conscience.” In informal comments from preeminent defender of media First Amendment rights, Floyd Abrams, he recounted his long history of serving as counsel to media organizations whose First Amendment rights were threatened. Notwithstanding that history, Abrams states, “but knowing and repeated distortion of information about a forthcoming election is precisely what a broadcaster may not do, and that the Commission may consider in determining whether license renewal is appropriate.” The joint informal comments were filed by Brian Hansbury, MAD’s Co-founder; Alfred Sikes, former Republican Chairman of the FCC, Ervin S. Duggan, former Democratic FCC Commissioner and former PBS President, William Kristol, longtime Editor of The Weekly Standard, William Reyner, longtime lead regulatory and commercial outside counsel To Murdoch/Fox, and Preston Padden, former executive of Fox Broadcasting Company and former lead lobbyist for Rupert Murdoch/News Corporation/Fox. A copy of the informal comments is available here. A link to a timeline of MAD’s petition is available here. The Media and Democracy Project: MAD is a non-partisan, all-volunteer, grassroots organization focused on strengthening a free and independent media in the public interest. MAD aims to improve our national discourse so that American voters can engage in informed decision-making. As part of that goal, MAD has an interest in the responsibility of journalists and media to report fully, accurately, and fairly on the electoral process and the outcome of elections. Additional information is available at www.MediaAndDemocracyProject.Org. Contact Details Aaron Alberico +1 202-744-0786 aalberico@raynoravenue.com Company Website https://www.mediaanddemocracyproject.org/

November 19, 2024 08:00 AM Eastern Standard Time

New AI-Powered Mobile App Delivers Early Prediction of Heart Attack or Stroke

Before Health Intelligence Ltd.

Before Health Intelligence, Ltd. today emerged from stealth and announced a new mHealth app called Antshrike ™ that uses AI to transform wearable device data into highly precise and specific predictive cardiovascular health warnings. As an iOS app, Antshrike uses proprietary AI algorithms to identify early warning signs of critical cardiovascular events, such as heart attacks or strokes, with high predictive accuracy for individuals at risk. The app processes biometric time-series data collected by commercially available Apple smart phones and smart watches, calculates individual risk of critical events in real time and predicts when and how changes in a patient’s health states may occur. By notifying patients of imminent danger in advance, Antshrike enables timely intervention by healthcare providers, paving the way for personalized medical intervention and treatment and improved medical outcomes. “In South America, the Antshrike bird warns primates of upcoming dangers,” said Before Health Intelligence CEO & co-founder Ekaterina Mitricheva, MD, PhD. “We developed our new digital health app by the same name to warn those at risk of major ischemic cardiovascular events before they take place. With cardiovascular disease as the number one cause of death worldwide, there is an urgent need to predict and prevent heart attacks and strokes.” The Antshrike mHealth app: Passively monitors health status without interrupting daily routines, social interactions and work habits Predicts the danger and timing of cardiovascular events with more than 85% accuracy in a personalized manner Uses proven science based on decades of research, more than 130 billion data points analyzed by Before Health Intelligence’s scientists, as well as open source CDC data from tens of thousands of individuals Assures HIPAA-compliant patient privacy by preprocessing individual patient data (not patient records) on a patient’s phone with anonymized preprocessed values that can never be traced back to any specific person Requires no manual input of data or reliance on expensive hospital equipment and procedures Assists healthcare providers in saving more lives since timely predictive interventions are known to reduce the probability of lasting effects or fatality Antshrike uses two layers of AI, static and dynamic, to calculate an individual’s risk of critical events in real-time. The static layer processes data entered by an individual to determine an initial risk score, and the machine learning algorithm is trained on over 500,000 CDC datapoints of approximately 23,000 individuals. The dynamic layer collects and analyzes biometric time-series from smart watches in real-time, uses the proprietary AI algorithm to identify early warning signs of critical state transitions, and then delivers a personalized, time-sensitive risk score for an upcoming major ischemic cardiovascular event. The freemium app is expected to be available in the U.S. in 2025. To become a partner or learn more about the product, visit https://www.before-intelligence.com/contact. About Before Health Intelligence Ltd. Before Health Intelligence, a medical device manufacturer developing software-as-a-medical device (SaMD), offers mobile applications that identify the early warning signs of critical events in complex diseases. The apps analyze each individual’s health data, recorded by leading smart watch brands in combination with proprietary AI algorithms and data sets, as well as open source data from the Center for Disease Control (CDC). This continuous monitoring alerts individuals of early warning signs of critical cardiovascular events (e.g., heart attacks or strokes) or neuropsychiatric events (e.g., alcohol addiction relapse), enabling timely medical intervention and improved survival rates. Founded in 2022, the Before Health Intelligence team is comprised of highly skilled medical professionals, mathematicians, physicists and programmers with research experience at institutions such as Princeton University, Max Planck Society and MIT. Learn more at https://www.before-intelligence.com and follow the company on LinkedIn. Contact Details Rainier Communications Michelle Allard McMahon or Jenna Desimone beforehealth@rainierco.com Company Website https://www.before-intelligence.com/

November 19, 2024 07:45 AM Eastern Standard Time

Image

Bacula Announces Version 18.2 of its Backup and Recovery Software with New HPC Features

Bacula Systems

Expanding its leadership in high security, high performance backup and recovery for HPC and other demanding IT environments, Bacula Systems today announced a host of new features in the latest version of its backup and recovery software. Version 18.2 introduces powerful new features that enhance Bacula’s ability to support backup across a wide variety of different Virtual Machine-types. This comes as the industry continues its shift towards more economical alternatives to traditional VM’s. "This latest Bacula release underscores its unique ability to handle backups for numerous virtual machine types, enabling organizations to boost security, comply with regulatory demands, and achieve substantial cost savings," said Frank Barker, CEO of Bacula Systems. The new features in Version 18.2 further strengthen Bacula's top-tier security capabilities while enhancing its adaptability to meet the demands of complex IT environments—especially in terms of supporting various VM types and workloads. Its broad hybrid cloud qualities are now expanded with Lock function, immutability synchronization and storage class function for all cloud providers. Bacula’s advanced security features a number of innovative security tools, such as data poisoning detection, centralized encryption, FIPS 140-3 compliance, and an extensive cybersecurity dashboard for single-pane security control. Bacula now offers advanced backup and recovery capabilities for the following Virtual Machines: Nutanix, VMware, Hyper-V, KVM, Xen, XCP-ng, RHV and OpenStack. XCP-ng support now includes Secure mode. Version 18.2 offers Single Item Restore to all Hypervisor plugins. It also delivers Hypervisor to Cloud (EC2) conversion capabilities, a feature that provides the ability to send On-Premise backed-up virtual machines to the cloud to avoid lock-in situations with Hypervisor vendors and to help with migration strategies. Increased Hyper-V capabilities Bacula’s latest version offers the following enhancements for Hyper-V WinAPI to complement its ability to backup Virtual Machines in an agentless manner: Support for any kind of deployment (standalone or clustered) Advanced boot handling (UEFI based systems, device order management) Full, Differential or Incremental backup Data directly streamed from the source to the destination storage without the need of reserving any space on the backup agent running the process. Version 18.2 makes further additions to its comprehensive Kubernetes module, adding intelligence to select automatically the better backup mode or to protect additional services within a cluster such as the Ingress resource manager, among other improvements to increase its flexibility to support any kind of Kubernetes deployment. Applications and Databases additions include: Amazon Relational Database (RDS) Plugin: It is now possible to not only orchestrate Database as a Service backups in Amazon cloud, but also to extract the data and have it available OnPremise for increased protection or for migration purposes. M365 Plugin improvements: SharePoint module now has page-level recovery capabilities. Exchange module can now export its data to PST format and the new Activity module was added to protect logs on the actions performed on the Cloud service, which complements one of the most comprehensive M365 solutions in the industry. HPC Leadership: Bacula’s dominance in the HPC space is underlined by its remarkable scalability, Quobyte support and efficiency improvements to Bacula’s Big File Split module, which greatly accelerates the backup of environments with billions of files. ZFS advanced support, through extremely high performance design, will soon be available. In addition, Bacula has further developed its renowned Deduplication capability, with new and more powerful scan & recovery tools. "Bacula offers licensing without capacity limits, supports 34 different operating systems, leads the industry in security, scales extensively, provides in-cloud functionality, and is compatible with more hypervisor and container types than any other backup provider. Its unmatched flexibility delivers significant advantages for our military, government, e-commerce, ISV, and HPC clients"said Jorge Gea, CTO, Bacula Systems. Bacula Systems customers include NASA, Navisite, Texas A&M University, Sky PLC, Warner Bros, Locaweb and many more. About Bacula Systems: Bacula Enterprise Edition is a highly scalable backup and recovery software for large organizations, data centers and MSPs. www.baculasystems.com OpenStack and the OpenStack logos are trademarks of the OpenStack Foundation. Quobyte is a registered trademark of Quobyte Inc. Contact Details Bacula Systems Corp Rob Morrison +41 21 508 29 36 rob.morrison@baculasystems.com Company Website https://www.baculasystems.com/

November 19, 2024 07:12 AM Eastern Standard Time

1 2 3 4 5 ... 638